Advertisement
Screener

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

ARROWHEAD PHARMACEUTICALS, INC. Amortization of Intangible Assets

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Amortization of Intangible Assets of $400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-04

  • ARROWHEAD PHARMACEUTICALS, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $400.00K, a 0.00% change year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $400.00K, a 0.00% change year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $400.00K, a 0.00% change year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $400.00K, a 0.00% change year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2025 was $1.70M, a 0.00% change from fiscal 2024.
  • ARROWHEAD PHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2024 was $1.70M, a 0.00% change from fiscal 2023.
  • ARROWHEAD PHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2023 was $1.70M, a 0.00% change from fiscal 2022.
  • ARROWHEAD PHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2022 was $1.70M, a 0.00% change from fiscal 2021.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 3 month as first filedAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 6 month as first filedAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 9 month as first filedAmortization of Intangible Assets 12 monthAmortization of Intangible Assets 12 month as first filedAmortization of Intangible Assets 98 monthAmortization of Intangible Assets 101 monthAmortization of Intangible Assets 104 month
2026-06-30$400.00K
10-Q · filed 2026-08-04
$800.00K
derived: sum of 2 quarters · filed 2026-08-04
$1.30M
10-Q · filed 2026-08-04
$1.60M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$400.00K
10-Q · filed 2026-05-07
$900.00K
10-Q · filed 2026-05-07
$1.20M
derived: sum of 3 quarters · filed 2026-05-07
$1.60M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$400.00K
10-Q · filed 2026-02-05
$800.00K
derived: sum of 2 quarters · filed 2026-02-05
$1.20M
derived: sum of 3 quarters · filed 2026-08-04
$1.60M
derived: sum of 4 quarters · filed 2026-08-04
2025-09-30$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
$800.00K
derived: sum of 2 quarters · filed 2026-08-04
$1.20M
derived: sum of 3 quarters · filed 2026-08-04
$1.70M
10-K · filed 2025-11-25
2025-06-30$400.00K
10-Q · filed 2026-08-04
$800.00K
derived: sum of 2 quarters · filed 2026-08-04
$1.30M
10-Q · filed 2026-08-04
$1.60M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$400.00K
10-Q · filed 2026-05-07
$900.00K
10-Q · filed 2026-05-07
$1.20M
derived: sum of 3 quarters · filed 2026-05-07
$1.60M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$400.00K
10-Q · filed 2026-02-05
$800.00K
derived: sum of 2 quarters · filed 2026-02-05
$1.20M
derived: sum of 3 quarters · filed 2026-02-05
$1.60M
derived: sum of 4 quarters · filed 2026-02-05
2024-09-30$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
$800.00K
derived: sum of 2 quarters · filed 2025-11-25
$1.20M
derived: sum of 3 quarters · filed 2025-11-25
$1.70M
10-K · filed 2025-11-25
2024-06-30$400.00K
10-Q · filed 2025-08-07
$800.00K
derived: sum of 2 quarters · filed 2025-08-07
$1.30M
10-Q · filed 2025-08-07
$1.60M
derived: sum of 4 quarters · filed 2025-11-25
2024-03-31$400.00K
10-Q · filed 2025-05-12
$900.00K
10-Q · filed 2025-05-12
$1.20M
derived: sum of 3 quarters · filed 2025-11-25
$1.60M
derived: sum of 4 quarters · filed 2025-11-25
2023-12-31$400.00K
10-Q · filed 2025-02-10
$800.00K
derived: sum of 2 quarters · filed 2025-11-25
$1.20M
derived: sum of 3 quarters · filed 2025-11-25
$1.60M
derived: sum of 4 quarters · filed 2025-11-25
2023-09-30$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
$800.00K
derived: sum of 2 quarters · filed 2025-11-25
$1.20M
derived: sum of 3 quarters · filed 2025-11-25
$1.70M
10-K · filed 2025-11-25
2023-06-30$400.00K
10-Q · filed 2024-08-08
$800.00K
derived: sum of 2 quarters · filed 2024-08-08
$1.30M
10-Q · filed 2024-08-08
$1.60M
derived: sum of 4 quarters · filed 2024-11-26
2023-03-31$400.00K
10-Q · filed 2024-05-09
$900.00K
10-Q · filed 2024-05-09
$1.20M
derived: sum of 3 quarters · filed 2024-11-26
$1.60M
derived: sum of 4 quarters · filed 2024-11-26
2022-12-31$400.00K
10-Q · filed 2024-02-06
$800.00K
derived: sum of 2 quarters · filed 2024-11-26
$1.20M
derived: sum of 3 quarters · filed 2024-11-26
$1.60M
derived: sum of 4 quarters · filed 2024-11-26
2022-09-30$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26
$800.00K
derived: sum of 2 quarters · filed 2024-11-26
$1.20M
derived: sum of 3 quarters · filed 2024-11-26
$1.70M
10-K · filed 2024-11-26
2022-06-30$400.00K
10-Q · filed 2023-08-07
$800.00K
derived: sum of 2 quarters · filed 2023-08-07
$1.30M
10-Q · filed 2023-08-07
$1.28M
10-Q · filed 2022-08-04
$1.60M
derived: sum of 4 quarters · filed 2023-11-29
2022-03-31$400.00K
10-Q · filed 2023-05-02
$900.00K
10-Q · filed 2023-05-02
$1.20M
derived: sum of 3 quarters · filed 2023-11-29
$1.60M
derived: sum of 4 quarters · filed 2023-11-29
2021-12-31$400.00K
10-Q · filed 2023-02-06
$425.00K
10-Q · filed 2022-02-02
$800.00K
derived: sum of 2 quarters · filed 2023-11-29
$1.20M
derived: sum of 3 quarters · filed 2023-11-29
$1.60M
derived: sum of 4 quarters · filed 2023-11-29
2021-09-30$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29
$800.00K
derived: sum of 2 quarters · filed 2023-11-29
$1.20M
derived: sum of 3 quarters · filed 2023-11-29
$1.70M
10-K · filed 2023-11-29
2021-06-30$400.00K
10-Q · filed 2022-08-04
$800.00K
derived: sum of 2 quarters · filed 2022-08-04
$1.30M
10-Q · filed 2022-08-04
$1.27M
10-Q · filed 2021-08-05
$1.60M
derived: sum of 4 quarters · filed 2022-11-28
2021-03-31$400.00K
10-Q · filed 2022-05-10
$850.00K
10-Q · filed 2022-05-10
$1.20M
derived: sum of 3 quarters · filed 2022-11-28
$1.60M
derived: sum of 4 quarters · filed 2022-11-28
2020-12-31$400.00K
10-Q · filed 2022-02-02
$425.00K
10-Q · filed 2021-02-04
$800.00K
derived: sum of 2 quarters · filed 2022-11-28
$1.20M
derived: sum of 3 quarters · filed 2022-11-28
$1.60M
derived: sum of 4 quarters · filed 2022-11-28
2020-09-30$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28
$800.00K
derived: sum of 2 quarters · filed 2022-11-28
$1.20M
derived: sum of 3 quarters · filed 2022-11-28
$1.70M
10-K · filed 2022-11-28
$1.70M
10-K · filed 2020-11-23
2020-06-30$400.00K
10-Q · filed 2021-08-05
$425.11K
10-Q · filed 2020-08-05
$800.00K
derived: sum of 2 quarters · filed 2021-08-05
$1.30M
10-Q · filed 2021-08-05
$1.28M
10-Q · filed 2020-08-05
$1.62M
derived: sum of 4 quarters · filed 2021-11-22
2020-03-31$400.00K
10-Q · filed 2021-05-04
$425.11K
10-Q · filed 2020-05-07
$900.00K
10-Q · filed 2021-05-04
$850.21K
10-Q · filed 2020-05-07
$1.22M
derived: sum of 3 quarters · filed 2021-11-22
$1.65M
derived: sum of 4 quarters · filed 2021-11-22
2019-12-31$400.00K
10-Q · filed 2021-02-04
$425.11K
10-Q · filed 2020-02-05
$824.68K
derived: sum of 2 quarters · filed 2021-11-22
$1.25M
derived: sum of 3 quarters · filed 2021-11-22
$1.67M
derived: sum of 4 quarters · filed 2021-11-22
2019-09-30$424.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22
$849.78K
derived: sum of 2 quarters · filed 2021-11-22
$1.27M
derived: sum of 3 quarters · filed 2021-11-22
$1.70M
10-K · filed 2021-11-22
$1.70M
10-K · filed 2019-11-25
2019-06-30$425.11K
10-Q · filed 2020-08-05
$850.22K
derived: sum of 2 quarters · filed 2020-08-05
$1.28M
10-Q · filed 2020-08-05
$1.70M
derived: sum of 4 quarters · filed 2020-11-23
2019-03-31$425.11K
10-Q · filed 2020-05-07
$850.22K
10-Q · filed 2020-05-07
$1.28M
derived: sum of 3 quarters · filed 2020-11-23
$1.70M
derived: sum of 4 quarters · filed 2020-11-23
2018-12-31$425.11K
10-Q · filed 2020-02-05
$850.21K
derived: sum of 2 quarters · filed 2020-11-23
$1.28M
derived: sum of 3 quarters · filed 2020-11-23
$1.70M
derived: sum of 4 quarters · filed 2020-11-23
2018-09-30$425.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23
$850.21K
derived: sum of 2 quarters · filed 2020-11-23
$1.28M
derived: sum of 3 quarters · filed 2020-11-23
$1.70M
10-K · filed 2020-11-23
2018-06-30$425.11K
10-Q · filed 2019-08-05
$850.21K
derived: sum of 2 quarters · filed 2019-08-05
$1.28M
10-Q · filed 2019-08-05
$1.70M
derived: sum of 4 quarters · filed 2019-11-25
2018-03-31$425.11K
10-Q · filed 2019-05-08
$850.21K
10-Q · filed 2019-05-08
$850.22K
10-Q · filed 2018-05-08
$1.28M
derived: sum of 3 quarters · filed 2019-11-25
$1.70M
derived: sum of 4 quarters · filed 2019-11-25
2017-12-31$425.11K
10-Q · filed 2019-02-07
$850.21K
derived: sum of 2 quarters · filed 2019-11-25
$1.28M
derived: sum of 3 quarters · filed 2019-11-25
$1.70M
derived: sum of 4 quarters · filed 2019-11-25
2017-09-30$425.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25
$850.21K
derived: sum of 2 quarters · filed 2019-11-25
$1.28M
derived: sum of 3 quarters · filed 2019-11-25
$1.70M
10-K · filed 2019-11-25
2017-06-30$425.11K
10-Q · filed 2018-08-07
$850.21K
derived: sum of 2 quarters · filed 2018-08-07
$1.28M
10-Q · filed 2018-08-07
$1.70M
derived: sum of 4 quarters · filed 2018-12-11
2017-03-31$425.11K
10-Q · filed 2018-05-08
$850.22K
10-Q · filed 2018-05-08
$1.28M
derived: sum of 3 quarters · filed 2018-12-11
$1.70M
derived: sum of 4 quarters · filed 2018-12-11
2016-12-31$425.11K
10-Q · filed 2018-02-09
$850.21K
derived: sum of 2 quarters · filed 2018-12-11
$1.28M
derived: sum of 3 quarters · filed 2018-12-11
$1.70M
derived: sum of 4 quarters · filed 2018-12-11
2016-09-30$425.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11
$850.21K
derived: sum of 2 quarters · filed 2018-12-11
$1.28M
derived: sum of 3 quarters · filed 2018-12-11
$1.71M
10-K · filed 2018-12-11
2016-06-30$425.11K
10-Q · filed 2017-08-03
$850.21K
derived: sum of 2 quarters · filed 2017-08-03
$1.29M
10-Q · filed 2017-08-03
$1.73M
derived: sum of 4 quarters · filed 2017-12-12
2016-03-31$425.11K
10-Q · filed 2016-05-10
$864.10K
10-Q · filed 2016-05-10
$1.30M
derived: sum of 3 quarters · filed 2017-12-12
$1.74M
derived: sum of 4 quarters · filed 2017-12-12
2015-12-31$438.99K
10-Q · filed 2017-02-06
$877.76K
derived: sum of 2 quarters · filed 2017-12-12
$1.32M
derived: sum of 3 quarters · filed 2017-12-12
$1.47M
derived: sum of 4 quarters · filed 2017-12-12
2015-09-30$438.77K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12
$877.54K
derived: sum of 2 quarters · filed 2017-12-12
$1.03M
derived: sum of 3 quarters · filed 2017-12-12
$1.05M
10-K · filed 2017-12-12
2015-06-30$438.77K
10-Q · filed 2016-08-09
$594.14K
derived: sum of 2 quarters · filed 2016-08-09
$607.80K
10-Q · filed 2016-08-09
$621.46K
derived: sum of 4 quarters · filed 2016-12-14
2015-03-31$155.37K
10-Q · filed 2016-05-10
$169.03K
10-Q · filed 2016-05-10
$182.69K
derived: sum of 3 quarters · filed 2016-12-14
$196.36K
derived: sum of 4 quarters · filed 2016-12-14
2014-12-31$13.66K
10-Q · filed 2016-02-09
$27.33K
derived: sum of 2 quarters · filed 2016-12-14
$40.99K
derived: sum of 3 quarters · filed 2016-12-14
$54.65K
derived: sum of 4 quarters · filed 2016-12-14
2014-09-30$13.66K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14
$27.33K
derived: sum of 2 quarters · filed 2016-12-14
$40.99K
derived: sum of 3 quarters · filed 2016-12-14
$54.65K
10-K · filed 2016-12-14
2014-06-30$13.66K
10-Q · filed 2015-08-04
$27.33K
derived: sum of 2 quarters · filed 2015-08-04
$40.99K
10-Q · filed 2015-08-04
$54.65K
derived: sum of 4 quarters · filed 2015-12-14
2014-03-31$13.66K
10-Q · filed 2015-05-11
$27.33K
10-Q · filed 2015-05-11
$40.99K
derived: sum of 3 quarters · filed 2015-12-14
$115.11K
derived: sum of 4 quarters · filed 2015-12-14
2013-12-31$13.66K
10-Q · filed 2015-02-09
$13.66K
10-Q · filed 2014-02-04
$27.33K
derived: sum of 2 quarters · filed 2015-12-14
$101.44K
derived: sum of 3 quarters · filed 2015-12-14
$175.56K
derived: sum of 4 quarters · filed 2015-12-14
2013-09-30$13.66K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14
$87.78K
derived: sum of 2 quarters · filed 2015-12-14
$161.89K
derived: sum of 3 quarters · filed 2015-12-14
$236.01K
10-K · filed 2015-12-14
2013-06-30$74.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07
$148.23K
derived: sum of 2 quarters · filed 2013-08-07
$222.34K
10-Q · filed 2013-08-07
2013-03-31$74.11K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09
$148.23K
10-Q · filed 2013-05-09
2012-12-31$74.11K
10-Q · filed 2013-02-13
2012-09-30$293.96K
10-K · filed 2014-11-25
2011-12-31$71.62K
10-Q · filed 2012-02-09
$132.07K
derived: sum of 2 quarters · filed 2012-12-28
$192.52K
derived: sum of 3 quarters · filed 2012-12-28
$1.85M
10-Q · filed 2012-02-09
2011-09-30$60.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28
$120.90K
derived: sum of 2 quarters · filed 2012-12-28
$241.81K
10-K · filed 2012-12-28
$1.78M
10-K · filed 2011-12-20
2011-06-30$60.45K
10-Q · filed 2011-08-08
$181.36K
10-Q · filed 2011-08-08
$1.72M
10-Q · filed 2011-08-08
2010-12-31$60.45K
10-Q · filed 2012-02-09
$120.90K
derived: sum of 2 quarters · filed 2012-02-09
$181.36K
derived: sum of 3 quarters · filed 2012-02-09
2010-09-30$60.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20
$120.90K
derived: sum of 2 quarters · filed 2011-12-20
$241.81K
10-K · filed 2011-12-20
2010-06-30$60.45K
10-Q · filed 2011-08-08
$181.36K
10-Q · filed 2011-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Alkermes plc. (ALKS)$6.844B132.74